The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
Jasmine M. Manouchehri(The Ohio State University Wexner Medical Center), Mathew Cherian(The Ohio State University Wexner Medical Center)
Cited by 0
Related Papers
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
|npj Breast Cancer|2021|37
An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia
|Journal of Biological Chemistry|2018|27
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
|Frontiers in Oncology|2022|20
Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment
|Anticancer Research|2017|7
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
|Breast Cancer Research|2024|7